Abstract

The sudden and deadly onset of the Coronavirus-19 (COVID-19) pandemic has led to a worldwide demand for vaccinations, as governments and organizations attempt to safeguard public health through mass immunization. However, the unique nature of COVID-19 combined with previous lessons from mass inoculation programmes has made vaccine manufacturers more cautious. Indeed, indemnification from Adverse Effects post Inoculation (AEIs) caused by vaccinations, which in previous health crises was not granted to vaccine manufacturing companies, is increasingly sought and guaranteed to them by governments across the world. This article analyses the alternative means to settle victims’ AEI claims that have been evolved by governments and organizations, as well as the legal and moral issues arising from the same.

Keywords